Ovarian Cancer | Tumor

Long-Term Evidence Confirms Benefit of Approved Lynparza Maintenance Strategy in Advanced Ovarian Cancer

September 29th 2020, 7:00pm

Article

Five-year follow-up data from the phase 3 SOLO-1 trial demonstrates a nearly five-year delay in disease progression with Lynparza compared with a delay of just over a year with placebo in women with newly diagnosed, advanced ovarian cancer harboring a BRCA gene mutation.

Dose-Dense Chemo Regimen No Better Than Standard of Care for Epithelial Ovarian Cancer

September 28th 2020, 6:00pm

Article

A weekly high dose of chemotherapy did not improve survival for patients with epithelial ovarian cancer, though the treatment regimen was effective and well-tolerated.

Study Finds Premenopausal Women Facing Increased Ovarian Cancer Risk Favor Removing Fallopian Tubes But Save Ovaries

September 11th 2020, 9:00pm

Article

A proposed preventive surgery that would take out fallopian tubes before menopause but save ovary removal until afterwards was favored by most premenopausal previvors of ovarian cancer in a study.

Patients with Ovarian Cancer Suggest Using Visual Learning Aids and Simplified Language to Better Help Them Understand Genetic Testing and Counseling

September 11th 2020, 6:00pm

Article

The study results also showed that older age was significantly associated with lower cancer genetics knowledge, which, according to a post-doctoral research fellow at Dana-Farber Cancer Institute, is important because older adults may serve as a resource for family members who seek information about their family's health history.

Mektovi Fails to Improve Progression-Free Survival in Rare Ovarian Cancer Subset, But Shows Effective Results

September 10th 2020, 9:00pm

Article

Compared to physician’s choice of chemotherapy, the MEK inhibitor Mektovi failed to improve progression-free survival in patients with low-grade serous ovarian carcinomas. However, the study authors note Mektovi demonstrated promising results that support continued use of the treatment.

National Ovarian Cancer Coalition to Host Annual Together in Teal® Event

September 8th 2020, 3:54pm

Article

The National Ovarian Cancer Coalition to host its annual "Together in Teal®" No Boundaries National Broadcast Celebration During September awareness month on Saturday, Septemeber 26, 2020.

Lynparza Maintenance Delays Disease Progression for Advanced BRCA-Positive Ovarian Cancer

September 3rd 2020, 6:00pm

Article

Immediate treatment with Lynparza after standard surgery and chemotherapy should be considered for all patients with newly diagnosed stage 3 or 4 ovarian cancer that carries a BRCA gene mutation, even if residual disease remains, researchers have found.

Women with Endometrial and Ovarian Cancers Experience Significant Fatigue Following Surgery

August 28th 2020, 6:00pm

Article

Nearly half (48%) of the patients reported experiencing significant fatigue following their surgery. Thirty-nine percent of the patients still reported significant fatigue one year following their surgery.

CURE’s Clinical Trial Corner: August 2020

August 27th 2020, 1:00pm

Article

Here is a list of the recent trial initiations that occurred within the cancer space in August.

Mortality Rate of Patients with Gynecological Cancers and COVID-19 Similar to Age Specific Risk

August 18th 2020, 1:30pm

Article

While 75% of patients with gynecological cancers and COVID-19 will recover, new data from New York City shows specific risks for patients with cancer infected with COVID-19.